Author Information
Krzysztof Adam Simon is a distinguished researcher affiliated with the Department of Infectious Diseases and Hepatology at Wroclaw Medical University in Poland. His work primarily focuses on the field of infectious diseases, with a particular emphasis on viral infections such as Hepatitis C Virus (HCV) and COVID-19. Simon's contributions to the medical community are significant, given his expertise in epidemiology and infectiology, which are critical areas in understanding and managing infectious diseases.Research Contributions
Krzysztof Adam Simon has made substantial contributions to the study and management of infectious diseases through his research. In 2022, he examined the influence of HCV genotype on the incidence of diabetes, as part of the EpiTer Multicentre Study. His work also extends to the management of SARS-CoV-2 infection, where he provided recommendations in collaboration with the Polish Association of Epidemiologists and Infectiologists. Simon has also investigated severe breakthrough COVID-19 cases during the Delta variant's dominance in Poland. His research interests include supporting COVID-19 vaccination efforts, evaluating imaging techniques for COVID-19 diagnosis, and analyzing treatments such as Tocilizumab for COVID-19 patients with high IL-6 levels. Additionally, Simon has explored triage tools, early predictors of mortality in COVID-19, and effective treatments for challenging HCV cases.Aliases
Krzysztof Adam Simon is known by several aliases in academic publications, which include Krzysztof Simon, Krzysztof A. Simon, K. Simon, Krzysztof A Simon, and K Simon.Publication and Citation Metrics
| Citation Count |
3699 |
| H-index |
24 |
| Paper Count |
203 |
